Dr. Ramon H. Parrilla, MD Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: State Road # 787 Km. 1.5, First Hospital Panamericano, Cidra, PR 00739 Phone: 787-739-8075 Fax: 787-739-5544 |
Amarilis Huertas-rivera, Psychiatry & Neurology - Psychosomatic Medicine Medicare: Not Enrolled in Medicare Practice Location: Km 1.5, Pr-787, Cidra, 00739, First Hospital Panamericano, Cidra, PR 00739 Phone: 787-739-5555 |
Mr. Hilson Acosta, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Bo Arena Carr 734, Cidra, PR 00739 Phone: 787-641-0774 Fax: 787-641-2759 |
Dr. Luis Ramon Alvarado, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Carr 787 Km 1.5, Hospital Panamericano, Cidra, PR 00739 Phone: 787-739-8830 |
News Archive
This summer, more than 55 researchers participating in the Alzheimer's Breakthrough Ride are cycling relay-style across the country, collecting petition signatures asking Congress to make Alzheimer's disease a national priority. The public response to the petition has been so overwhelming that as the Alzheimer's Breakthrough Riders hit the halfway point in their 67-day route from San Francisco to Washington, D.C. on August 18, they are already more than 80% of the way to their goal of 50,000 signatures.
A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiCheck urine test for the detection of bladder cancer recurrence, were published in the European Urology Oncology journal.
A new study posted in the bioRxiv* preprint server used mouse models to investigate how mRNA vaccines elicit a rapid antibody response. Their findings show two different mRNA vaccines successfully boost antibody levels — IL-5, IL-6, and MCP-1 —5 days after administration.
› Verified 4 days ago